Cargando…

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population

The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality risk in various patient populations. However, little is known about the implications of lifestyle for suPAR levels in the general population. Lifestyle, demographic, and cardiovascular disease (CVD) risk factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Haupt, Thomas H, Kallemose, Thomas, Ladelund, Steen, Rasmussen, Line JH, Thorball, Christian W, Andersen, Ove, Pisinger, Charlotta, Eugen-Olsen, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269129/
https://www.ncbi.nlm.nih.gov/pubmed/25574132
http://dx.doi.org/10.4137/BMI.S19876
_version_ 1782349327818031104
author Haupt, Thomas H
Kallemose, Thomas
Ladelund, Steen
Rasmussen, Line JH
Thorball, Christian W
Andersen, Ove
Pisinger, Charlotta
Eugen-Olsen, Jesper
author_facet Haupt, Thomas H
Kallemose, Thomas
Ladelund, Steen
Rasmussen, Line JH
Thorball, Christian W
Andersen, Ove
Pisinger, Charlotta
Eugen-Olsen, Jesper
author_sort Haupt, Thomas H
collection PubMed
description The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality risk in various patient populations. However, little is known about the implications of lifestyle for suPAR levels in the general population. Lifestyle, demographic, and cardiovascular disease (CVD) risk factor data were collected from 5,538 participants in the Danish population-based Inter99 study. Their suPAR levels were measured using a sandwich enzyme-linked immunosorbent assay. In the final adjusted model, smoking and morbid obesity were strongly associated with higher suPAR levels (P < 0.001). An unhealthy diet and alcohol abstinence in men were also associated with higher suPAR levels. Physical activity in leisure time had a modest impact on suPAR levels in univariate analysis, but not in the final adjusted model. In conclusion, smoking and morbid obesity were strongly associated with higher serum suPAR levels in this general population. Diet and alcohol consumption also seemed to impact suPAR levels. Lifestyle changes are likely to affect suPAR since ex-smokers had suPAR levels comparable to those of never-smokers.
format Online
Article
Text
id pubmed-4269129
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-42691292015-01-08 Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population Haupt, Thomas H Kallemose, Thomas Ladelund, Steen Rasmussen, Line JH Thorball, Christian W Andersen, Ove Pisinger, Charlotta Eugen-Olsen, Jesper Biomark Insights Original Research The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality risk in various patient populations. However, little is known about the implications of lifestyle for suPAR levels in the general population. Lifestyle, demographic, and cardiovascular disease (CVD) risk factor data were collected from 5,538 participants in the Danish population-based Inter99 study. Their suPAR levels were measured using a sandwich enzyme-linked immunosorbent assay. In the final adjusted model, smoking and morbid obesity were strongly associated with higher suPAR levels (P < 0.001). An unhealthy diet and alcohol abstinence in men were also associated with higher suPAR levels. Physical activity in leisure time had a modest impact on suPAR levels in univariate analysis, but not in the final adjusted model. In conclusion, smoking and morbid obesity were strongly associated with higher serum suPAR levels in this general population. Diet and alcohol consumption also seemed to impact suPAR levels. Lifestyle changes are likely to affect suPAR since ex-smokers had suPAR levels comparable to those of never-smokers. Libertas Academica 2014-12-16 /pmc/articles/PMC4269129/ /pubmed/25574132 http://dx.doi.org/10.4137/BMI.S19876 Text en © 2014 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.
spellingShingle Original Research
Haupt, Thomas H
Kallemose, Thomas
Ladelund, Steen
Rasmussen, Line JH
Thorball, Christian W
Andersen, Ove
Pisinger, Charlotta
Eugen-Olsen, Jesper
Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
title Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
title_full Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
title_fullStr Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
title_full_unstemmed Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
title_short Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
title_sort risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269129/
https://www.ncbi.nlm.nih.gov/pubmed/25574132
http://dx.doi.org/10.4137/BMI.S19876
work_keys_str_mv AT hauptthomash riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation
AT kallemosethomas riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation
AT ladelundsteen riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation
AT rasmussenlinejh riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation
AT thorballchristianw riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation
AT andersenove riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation
AT pisingercharlotta riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation
AT eugenolsenjesper riskfactorsassociatedwithserumlevelsoftheinflammatorybiomarkersolubleurokinaseplasminogenactivatorreceptorinageneralpopulation